Revolution Medicines stockRVMD
Revolution Medicines trades at $177.65, 20.8% below its 52-week high (Aug 27, 2026). The price is below its 50-day but above its 200-day average: a pullback within an uptrend. +123.0% year to date, +199.4% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 1, 2027.
- Market pulseRevolution Medicines posts Q3 2026 results with $197.6M RASONQUE net product revenue and $3.7B cash balance
- Market pulseRevolution Medicines beats Q3 2026 revenue estimates with $197.6M RASONQUE net product revenue
- GlobeNewswireRevolution Medicines Reports Third Quarter 2026 Financial Results and Update on Corporate Progress
The trigger was the quarterly report: EPS −18% year over year, 19.0% above the estimate.
All moves of the day →Ratings, candles, signals and the screener for RVMD — after you log in
Open the terminalFrequently asked questions about Revolution Medicines
What is the Revolution Medicines stock price?
At the close on Nov 5, 2026: $177.65 (−11.04% on the day). 52-week high: $224.31 on Aug 27, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Revolution Medicines report earnings?
The next quarterly report is on Mar 1, 2027. Last quarter, earnings per share changed −18% year over year, revenue 0%.
Does Revolution Medicines pay dividends?
No, Revolution Medicines does not pay dividends.
Where does Revolution Medicines trade and how to buy it?
Ticker RVMD, exchange Nasdaq, listed since 2020. You can buy it through a broker with access to US exchanges.
Should I buy Revolution Medicines now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for RVMD are in the terminal after you log in.